osimertinib for egfr-mutant lung cancer
Published 3 years ago • 4.9K plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
2:06
continued use of osimertinib reduces cns metastasis in egfr mutant lung cancer
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
3:38
overview of the world of egfr mutant lung cancers
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:44
osimertinib and chemotherapy in egfr lung cancer with tp53 and rb1 alterations
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:18
egfr-mutant lung cancer: a patient's journey
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
3:54
teslisotuzumab vedotin and osimertinib for egfr-mutant, c-met-overexpressing nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
6:02
q & a with egfr-mutant lung cancer experts | 2024 living with egfr-mutant lung cancer patient forum
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
2:56
non-tki-based treatment options for egfr-mutant lung cancer
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
5:26
first-line osimertinib in egfr mutant ansclc patients: progression pattern and safety in the rea...